BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipopolysaccharide
,
rs3825942
,
DNMT1
,
T cell differentiation
,
Arthritis
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
as1842856
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
YPEL4
RMI2
PYCR1
CTSF
FBXO32
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PUJANA_BRCA1_PCC_NETWORK
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
RNA binding
LEE_BMP2_TARGETS_DN
DODD_NASOPHARYNGEAL_CARCINOMA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Acute lymphoblastic leukemia RS4-11 and UoC-B6 cells treated with FOXO1 inhibitor AS1842856
CD4+ T cells treated with the FOXO1 inhibitor AS1842856
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting FoxO1 with AS1842856 suppresses adipogenesis.
FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiom…
Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human …
Pharmacological inhibition of FOXO1 promotes lymphatic valve growth in a congenital lymphedema mouse…
FoxO1 Regulates Neuropeptide Y and Pro-opiomelanocortin in the Hypothalamus of Rat Offspring Small f…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for as1842856
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ